Literature DB >> 19757302

T-box-expressed-in-T-cells (T-bet) expression by the tumor cells of hairy-cell leukemia correlates with interferon-gamma production.

Korinna Jöhrens1, Verena Moos, Thomas Schneider, Ioannis Anagnostopoulos.   

Abstract

Hairy cell leukemia (HCL) is an uncommon B-cell malignancy with unknown pathogenesis. In an earlier study, we demonstrated that HCL cells highly express the transcription factor T-box-expressed-in-T-cells (T-bet). T-bet is the master regulator of the T-helper (Th)1 cell response regulating interferon gamma (IFN-gamma) production and also plays a central role in the T-cell independent Th1-like B-cell response. Here, we demonstrate by fluorescence activated cell sorting (FACS) analysis that neoplastic cells from the peripheral blood of five patients with HCL showed an enhanced expression of IFN-gamma after stimulation. Additionally, a comparison with 55 healthy individuals revealed a significant elevation of IFN-gamma in the sera of patients with HCL. Based on our recent findings that a non-neoplastic B-cell subset, the monocytoid B-cells, are T-bet positive and produce IFN-gamma, we propose that monocytoid and hairy B-cells have a similar function and that the T-bet-IFN-gamma axis is involved in the pathogenesis of HCL.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19757302     DOI: 10.1080/10428190903161042

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

Review 1.  Selective immunophenotyping for diagnosis of B-cell neoplasms: immunohistochemistry and flow cytometry strategies and results.

Authors:  Scott D Boyd; Yasodha Natkunam; John R Allen; Roger A Warnke
Journal:  Appl Immunohistochem Mol Morphol       Date:  2013-03

Review 2.  Development of B Cell Memory in Malaria.

Authors:  Ann Ly; Diana S Hansen
Journal:  Front Immunol       Date:  2019-04-02       Impact factor: 7.561

Review 3.  The Genomics of Hairy Cell Leukaemia and Splenic Diffuse Red Pulp Lymphoma.

Authors:  David Oscier; Kostas Stamatopoulos; Amatta Mirandari; Jonathan Strefford
Journal:  Cancers (Basel)       Date:  2022-01-29       Impact factor: 6.639

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.